Labiotech.eu

News and Trends 29 Jan 2018

Mapping of the Axolotl’s Genome Boosts the Regenerative Medicine Field

Salamanders have long been a useful model for regenerative medicine due to their ability to regrow entire limbs. Now, scientists have found the genes that drive the process. Scientists in Vienna, Dresden, and Heidelberg are the first to completely map the genome of the axolotl salamander. Despite its popularity as a biological model and use for […]

January 29, 2018 - 3 minutesmins - By Alex Dale

Interview 29 Jan 2018

Meet the CEO of the Other Big Biotech Acquisition Target in 2017

Christian Schetter’s company, Rigontec, was acquired by MSD last year for nearly half a billion euro. How did he and the company do it, with only one early-stage candidate? There were exactly two notable biotech acquisitions in Europe last year: Actelion and a smaller startup based in Munich called Rigontec, which had an RNA candidate […]

January 29, 2018 - 9 minutesmins - By Evelyn Warner

biology art berlin central station novozymes

News and Trends 27 Jan 2018

Biology and Art Take Over the Berlin Central Station

The art installation Relationscape connected many Berlin commuters with the future of biology at the capital’s central station. This week, the daily commuters of the German capital got a chance to come face to face with the world of biology. At the entrance of the Berlin Central Station, a huge building made of steel, glass […]

January 27, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 26 Jan 2018

New British Spinout May Get Snapped Up by Allergan for $400M

KaNDy Therapeutics, a women’s health spinout helmed by Mary Kerr, is rumored to be in acquisition talks that value the company at $400M (€322M). Details are sparse, but according to a report from Bloomberg, Stevenage-based KaNDy Therapeutics is supposedly in the late stages of a discussion with Allergan about a possible buyout. KaNDy, a recent spinout […]

January 26, 2018 - 1 minutemin - By Evelyn Warner

News and Trends 26 Jan 2018

Update: Bionic Implant Restores Vision in a Human for the First Time

Update (26/01/2018): A first patient was implanted with Pixium Vision’s PRIMA bionic device. A month after implantation, the device was activated and the patient, who suffered from severe vision loss due to age-related macular degeneration (AMD), reported “a first perception of light from the central zone where there was none previously,” according to principal investigator Dr. […]

January 26, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Startup Scout 26 Jan 2018

This Danish Biotech is Working on Better, Safer Drugs for Cardiac Arrhythmia

This week, we’re visiting Acesion Pharma in Copenhagen, a biotech that is developing more effective, safer drugs for atrial fibrillation, the most common form of cardiac arrhythmia. Mission: Since being founded in 2011, Acesion has already caught our attention, being named as one of our top biotechs in Copenhagen. The biotech focuses on the development of […]

January 26, 2018 - 2 minutesmins - By Alex Dale

News and Trends 25 Jan 2018

Yet More Good News for GW Pharma’s Cannabinoid Drug Against Epilepsy

New data in The Lancet provides further support for GW Pharma’s drug, Epidiolex, for the treatment of a rare form of epilepsy. GW Pharmaceuticals has achieved encouraging Phase III results for Epidiolex, which have been published in leading scientific journal, The Lancet. The company’s lead candidate is being developed for the treatment of epilepsy – a […]

January 25, 2018 - 3 minutesmins - By Alex Dale

News and Trends 25 Jan 2018

British Biotech Treats First Phase III Patient in its Critical Limb Ischemia Trial

Rexgenero has treated the first patient in a Phase III trial investigating REX-001, the biotech’s cell therapy for critical limb ischemia. Rexgenero is a biotech working on regenerative medicine techniques to treat critical limb ischemia (CLI). The condition is characterized by blocked arteries in the lower limbs that can force doctors to amputate. The company has […]

January 25, 2018 - 3 minutesmins - By Alex Dale

News and Trends 25 Jan 2018

Novartis Will Bring US Gene Therapy for Blindness to Europe

The Swiss pharma has bought into the gene editing therapy game in a deal with Spark worth $170M (€137M) for commercialization rights outside the US. Novartis first marked out its position as a gene therapy leader in 2012 when it threw its hat into the CAR-T ring. Just a few months after the FDA approved […]

January 25, 2018 - 2 minutesmins - By Evelyn Warner

In Depth 25 Jan 2018

What Happened to the Plans for a Smart Contact Lens for Diabetics?

Originally projected to be on the market by 2020, excitement about the contact lens to measure glucose levels from Novartis and Google has waned. Why? In 2016, smart wearables growth was steady but a recent study predicts that the market will pick up this year introducing innovative products to the consumer market: according to CCS Insight, the market for […]

January 25, 2018 - 5 minutesmins - By External Contributor

News and Trends 25 Jan 2018

Researchers Take Aim at Pancreatic Cancer with a Modified Flu Virus

In an early study at Queen Mary University in London, a modified flu virus has been able to block the growth of pancreatic cancer. For the first time, researchers at Queen Mary University, London, have shown that pancreatic cancer can be targeted using a modified flu virus. During a study, published in Molecular Cancer Therapeutics, […]

January 25, 2018 - 3 minutesmins - By Alex Dale

News and Trends 24 Jan 2018

New Retinitis Pigmentosa Treatments? This Blood-Retina Chip Could Help!

A new ‘organ-on-a-chip’ device for the blood-retina barrier could speed up the development of treatments for eye diseases like retinitis pigmentosa. Researchers from Microelectronics Institute of Barcelona, Vall d’Hebron Research Institute, and Universitat Autònoma de Barcelona have developed a microfluidic chip that mimics the human blood-retinal barrier in the eye. The study, published in Lab on a […]

January 24, 2018 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Mapping of the Axolotl’s Genome Boosts the Regenerative Medicine Field

Meet the CEO of the Other Big Biotech Acquisition Target in 2017

Biology and Art Take Over the Berlin Central Station

New British Spinout May Get Snapped Up by Allergan for $400M

Update: Bionic Implant Restores Vision in a Human for the First Time

This Danish Biotech is Working on Better, Safer Drugs for Cardiac Arrhythmia

Yet More Good News for GW Pharma’s Cannabinoid Drug Against Epilepsy

British Biotech Treats First Phase III Patient in its Critical Limb Ischemia Trial

Novartis Will Bring US Gene Therapy for Blindness to Europe

What Happened to the Plans for a Smart Contact Lens for Diabetics?

Researchers Take Aim at Pancreatic Cancer with a Modified Flu Virus

New Retinitis Pigmentosa Treatments? This Blood-Retina Chip Could Help!

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!